Human Medications, Human Drugs, Animal Medications, Animal Drugs, Pharmacy law, Pharmaceutical law, Compounding law, Sterile and Non Sterile Compounding 797 Compliance, Veterinary law, Veterinary
Compounding Law; Health Care; Awareness of all Types of Compounding Issues;
Pharmacy Benefit Managers (PBMs), Outsourcing Facilities
Food and Drug Administration and Compliance Issues
Wednesday, June 22, 2016
Medicare Part D spending on compounded drugs is skyrocketing - STAT STAT - 4 hours ago
Good to see the rise in spending is not being misread as an increase in demand for non-FDA-approved drugs, i.e., products that risk reaching patients without structured vetting for safety or effectiveness and frequently accompanied by layers of disclaimed warranty unknown to would-be and actual patients and prescribers. The skyrocketing spending appears to be the result of repurposed, questionable business models that exploit public payers (tax payers) reminiscent of the standardized, pre-printed prescriptions for compounded Part B nebulizer drugs from the days of yore.
1 comment:
Good to see the rise in spending is not being misread as an increase in demand for non-FDA-approved drugs, i.e., products that risk reaching patients without structured vetting for safety or effectiveness and frequently accompanied by layers of disclaimed warranty unknown to would-be and actual patients and prescribers. The skyrocketing spending appears to be the result of repurposed, questionable business models that exploit public payers (tax payers) reminiscent of the standardized, pre-printed prescriptions for compounded Part B nebulizer drugs from the days of yore.
Post a Comment